alanine has been researched along with peroxynitrous acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hollenberg, PF; Kent, UM; Lin, HL; Waskell, L; Zhang, H | 1 |
Akahoshi, T; Anegawa, G; Hashizume, M; Kawanaka, H; Kinjo, N; Konishi, K; Maehara, Y; Tanoue, K; Tarnawski, A; Tomikawa, M; Yamaguchi, S; Yoshida, D | 1 |
2 other study(ies) available for alanine and peroxynitrous acid
Article | Year |
---|---|
Mutation of tyrosine 190 to alanine eliminates the inactivation of cytochrome P450 2B1 by peroxynitrite.
Topics: Alanine; Amino Acid Substitution; Catalysis; Cytochrome P-450 CYP2B1; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Models, Molecular; Nitric Oxide; Peroxynitrous Acid; Recombinant Proteins; Spectrometry, Mass, Electrospray Ionization; Substrate Specificity; Tyrosine | 2003 |
Significance of ERK nitration in portal hypertensive gastropathy and its therapeutic implications.
Topics: Alanine; Animals; Enzyme Inhibitors; Ethanol; Extracellular Signal-Regulated MAP Kinases; Gastric Mucosa; Liver Cirrhosis; MAP Kinase Kinase Kinases; Nitrates; Oxidative Stress; Peroxynitrous Acid; Quinolones; Rats; Rats, Sprague-Dawley; Signal Transduction; Stomach Diseases; Tyrosine | 2008 |